Jiuzhitang announced that revenue for the third quarter was 554 million yuan, up 52.65% year on year; net profit was 53.755 million yuan, up 588.01% year on year. Revenue for the first three quarters was $2,186 million, up 34.34% year on year; net profit was 304 million yuan, up 100.33% year on year. The change in performance was mainly due to the increase in sales of some of the company's products in the current period and the inclusion of Harbin Jixianglong Biotechnology Co., Ltd. in the scope of the merger starting in November 2025. The company's Q3 net profit was 53 million and Q2 net profit was 85 million. Based on this calculation, Q3 net profit decreased 37% month-on-month.

Jiuzhitang announced that revenue for the third quarter was 554 million yuan, up 52.65% year on year; net profit was 53.755 million yuan, up 588.01% year on year. Revenue for the first three quarters was $2,186 million, up 34.34% year on year; net profit was 304 million yuan, up 100.33% year on year. The change in performance was mainly due to the increase in sales of some of the company's products in the current period and the inclusion of Harbin Jixianglong Biotechnology Co., Ltd. in the scope of the merger starting in November 2025. The company's Q3 net profit was 53 million and Q2 net profit was 85 million. Based on this calculation, Q3 net profit decreased 37% month-on-month.